Abstract
9615 Background: Aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) contribute to significant morbidity and therapy discontinuation. Retrospective data suggest that bisphosphonates may...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have